These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Type-dependent association between risk of cervical intraepithelial neoplasia and viral load of oncogenic human papillomavirus types other than types 16 and 18. Fu Xi L, Schiffman M, Ke Y, Hughes JP, Galloway DA, He Z, Hulbert A, Winer RL, Koutsky LA, Kiviat NB. Int J Cancer; 2017 Apr 15; 140(8):1747-1756. PubMed ID: 28052328 [Abstract] [Full Text] [Related]
3. Association of human papillomavirus type 31 variants with risk of cervical intraepithelial neoplasia grades 2-3. Xi LF, Schiffman M, Koutsky LA, Hulbert A, Lee SK, Defilippis V, Shen Z, Kiviat NB. Int J Cancer; 2012 Nov 15; 131(10):2300-7. PubMed ID: 22396129 [Abstract] [Full Text] [Related]
4. Human papillomavirus type 18 DNA load and 2-year cumulative diagnoses of cervical intraepithelial neoplasia grades 2-3. Xi LF, Koutsky LA, Castle PE, Wheeler CM, Galloway DA, Mao C, Ho J, Kiviat NB. J Natl Cancer Inst; 2009 Feb 04; 101(3):153-61. PubMed ID: 19176451 [Abstract] [Full Text] [Related]
5. [Evaluation of CIN2+ /CIN3+ risk of different HPV subtypes infection combined with abnormal cytology status]. Luo HX, Du H, Liu ZH, Zhang LJ, Wang C, Wu RF. Zhonghua Zhong Liu Za Zhi; 2018 Mar 23; 40(3):232-238. PubMed ID: 29575846 [Abstract] [Full Text] [Related]
6. Changes in DNA Level of Oncogenic Human Papillomaviruses Other Than Types 16 and 18 in Relation to Risk of Cervical Intraepithelial Neoplasia Grades 2 and 3. Xi LF, Schiffman M, Hughes JP, Galloway DA, Koutsky LA, Kiviat NB. Cancer Epidemiol Biomarkers Prev; 2019 Aug 23; 28(8):1388-1394. PubMed ID: 31101617 [Abstract] [Full Text] [Related]
7. Sensitivity and specificity values of high-risk HPV DNA, p16/ki-67 and HPV mRNA in young women with atypical squamous cells of undetermined significance (ASCUS) or low-grade squamous intraepithelial lesion (LSIL). Frega A, Pavone M, Sesti F, Leone C, Bianchi P, Cozza G, Colombrino C, Lukic A, Marziani R, De Sanctis L, Delli Carpini G, Caserta D, Ciavattini A. Eur Rev Med Pharmacol Sci; 2019 Dec 23; 23(24):10672-10677. PubMed ID: 31858534 [Abstract] [Full Text] [Related]
8. Minor Cytological Abnormalities and up to 7-Year Risk for Subsequent High-Grade Lesions by HPV Type. Persson M, Elfström KM, Olsson SE, Dillner J, Andersson S. PLoS One; 2015 Dec 23; 10(6):e0127444. PubMed ID: 26083247 [Abstract] [Full Text] [Related]
9. Expression of p16/Ki-67 in ASC-US/LSIL or Normal Cytology with Presence of Oncogenic HPV DNA. Solares C, Velasco J, Álvarez-Ruiz E, González-Fernández L, Encinas AI, Astudillo A, Schneider J. Anticancer Res; 2015 Nov 23; 35(11):6291-5. PubMed ID: 26504065 [Abstract] [Full Text] [Related]
10. Multiple human papillomavirus infections with high viral loads are associated with cervical lesions but do not differentiate grades of cervical abnormalities. Schmitt M, Depuydt C, Benoy I, Bogers J, Antoine J, Arbyn M, Pawlita M, VALGENT Study Group. J Clin Microbiol; 2013 May 23; 51(5):1458-64. PubMed ID: 23447632 [Abstract] [Full Text] [Related]
11. Prediction of cervical intraepithelial neoplasia grade 2+ (CIN2+) using HPV DNA testing after a diagnosis of atypical squamous cell of undetermined significance (ASC-US) in Catalonia, Spain. Ibáñez R, Moreno-Crespi J, Sardà M, Autonell J, Fibla M, Gutiérrez C, Lloveras B, Alejo M, Català I, Alameda F, Casas M, Bosch FX, de Sanjosé S. BMC Infect Dis; 2012 Jan 26; 12():25. PubMed ID: 22280073 [Abstract] [Full Text] [Related]
13. Human Papillomavirus Genotyping to Predict the Risk of Cervical Precancerous Lesions or Cancer in Women with Minor Abnormal Cytology in China. Lin CQ, Cui JF, Zhang X, Pan QJ, Chen W, Qiao YL. Acta Cytol; 2015 Jan 26; 59(5):405-11. PubMed ID: 26565687 [Abstract] [Full Text] [Related]
14. High-risk human papillomavirus genotype distribution and attribution to cervical cancer and precancerous lesions in a rural Chinese population. Zhao XL, Hu SY, Zhang Q, Dong L, Feng RM, Han R, Zhao FH. J Gynecol Oncol; 2017 Jul 26; 28(4):e30. PubMed ID: 28541628 [Abstract] [Full Text] [Related]
17. Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial. Canfell K, Caruana M, Gebski V, Darlington-Brown J, Heley S, Brotherton J, Gertig D, Jennett CJ, Farnsworth A, Tan J, Wrede CD, Castle PE, Saville M. PLoS Med; 2017 Sep 26; 14(9):e1002388. PubMed ID: 28926579 [Abstract] [Full Text] [Related]
20. Predicting CIN2+ when detecting HPV mRNA and DNA by PreTect HPV-proofer and consensus PCR: A 2-year follow-up of women with ASCUS or LSIL Pap smear. Molden T, Nygård JF, Kraus I, Karlsen F, Nygård M, Skare GB, Skomedal H, Thoresen SO, Hagmar B. Int J Cancer; 2005 May 10; 114(6):973-6. PubMed ID: 15645423 [Abstract] [Full Text] [Related] Page: [Next] [New Search]